Company Performance Metrics
Ralf Pasternack: Founder & CEO
Martin Hils: Managing PartnerPast Role: N Zyme BioTec, Head of R&D Molecular Genetics
Zedira GmbH is a clinical stage biotech company that specializes in transglutaminase. The company develops small molecular drug candidates and engages in the discovery of small molecules that block dysregulated transglutaminases. It is a global brand for specialty reagents for research and development as well as diagnostics in the transglutaminase
field. They offer TG6, a neuronal transglutaminase marker used in detecting neurological disorders caused by gluten.
The company also produces and markets specialty reagents to assist investigators who are studying celiac disease; and develops active ingredients and celiac disease diagnostic antigens. ZEDIRA GmbH also provides proteases, assays, substrates, antibodies, inhibitors, and autoantibody detection ELISA-Kits. Zedira was founded by Ralf Pasternack and Martin Hils in 2007; and is headquartered in Hessen, Germany.
